Accelerate Adoption of Galaxy Pro in the Biomedical Research Marketplace

加速 Galaxy Pro 在生物医学研究市场的采用

• 批准号: 10045292
• 负责人: Enis Afgan
• 金额: $ 5.5万
• 依托单位: GALAXYWORKS, LLC
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-13 至 2020-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10045292
• 关键词: Address; Adoption; Basic Science; Biological Assay; Biomedical Research; Businesses; Communities; Computer software; Computers; Data; Data Analyses; Data Storage and Retrieval; Environment; Galaxy; Generations; Goals; Improve Access; Individual; Innovation Corps; Institution; Laboratories; Mainstreaming; Methods; Pain; Phase; Positioning Attribute; Privatization; Process; Production; Research; Resources; Running; Science; Services; Small Business Technology Transfer Research; Training; base; collaborative environment; experience; flexibility; open source; precision medicine; product development; programs; tool; translational medicine; web interface; web-accessible

Project Summary Galactic Core LLC aims to develop a robust, scalable, and managed service for performing enterprise-grade biomedical data analysis. The service will be based on the popular open-source Galaxy application (​https://galaxyproject.org/​), offering unlimited data storage and compute capabilities with an extremely powerful, flexible, and collaborative environment for analyzing data. The service will be run as a set of private environments with dedicated computers being setup and managed for individuals, research groups, or institutions. Data generation assays and analysis tools in the Biomedical Sciences continue to evolve rapidly and fixed 1-click approach to data analysis is very challenging as the analysis must be quickly adapted to new methods and types of data. This landscape requires a proportionally vast and growing amount of capacity for data analysis that can be readily tailored to the domain and integrates with an array of external resources. Galaxy with its accessible web-interface and a worldwide community is uniquely positioned to adapt to this changing landscape as it provides access to >6,500 best-of-breed analysis tools and >100 data types. These numbers are unmatched by any similar solution, yet the rate at which tools and data types are added continues to increase. However, the challenges with setting up, maintaining, and evolving the necessary data analysis environment present an obstacle for biomedical data analysis, particularly for small firms and laboratories. The goal of our STTR Phase I project is to streamline the process of setting up and managing a production-quality instance of Galaxy and deliver it as a scalable, managed, always-on service. As part of this I-Corps program, we will identify customer pains and gains to better stear product development. Our goal for this program is to gain training and experience with customer discovery and business management as we develop this product-market fit. Broad and simple availability of a powerful biomedical data analysis platform would fundamentally improve access to biomedical data analysis capacity and facilitate routine analyses by research labs and institutions, small businesses, as well as mid-sized corporations.

项目摘要 Galaxy Core LLC的目标是为执行企业级任务开发强大、可扩展的托管服务 生物医学数据分析。该服务将基于广受欢迎的开源Galaxy应用程序 (https://galaxyproject.org/​​)，提供无限的数据存储和计算能力， 强大、灵活和协作的数据分析环境。该服务将作为一组私有 为个人、研究团队或个人设置和管理专用计算机的环境 机构。生物医学科学中的数据生成分析和分析工具继续快速发展 固定的一键式数据分析方法非常具有挑战性，因为分析必须快速适应新的 数据的方法和类型。这一环境需要相当庞大且不断增长的容量 数据分析可以很容易地为领域量身定做，并与一系列外部资源集成。 Galaxy凭借其可访问的网络界面和全球社区，处于独特的地位来适应这一点 变化的格局，因为它提供了对&gt；6,500个同类最佳分析工具和&gt；100数据类型的访问。这些 任何类似的解决方案都无法与数字匹配，但工具和数据类型的添加速度仍在继续 来增加。然而，建立、维护和发展必要的数据分析所面临的挑战 环境是生物医学数据分析的障碍，特别是对小公司和实验室来说。这个 我们STTR第一阶段项目的目标是简化建立和管理生产质量的流程 实例，并将其作为可扩展、托管、始终在线的服务提供。作为i-Corps计划的一部分， 我们将找出客户的痛苦和收获，以更好地指导产品开发。我们这个项目的目标是 随着我们的发展，获得客户发现和业务管理方面的培训和经验 产品与市场契合。强大的生物医学数据分析平台的广泛而简单的可用性将 从根本上提高获取生物医学数据的分析能力，促进通过研究进行常规分析 实验室和机构、小型企业以及中型企业。